CD44 and triple-negative breast carcinoma: In our research, we used the following two methods to improve the specificity and targeting ability to reduce the side effects of treatment: (1) we modified CO onto the surface of nanomaterials to actively target the high expression of CD44 in triple-negative breast cancer, and (2) through photodynamic therapy, we used 660 nm light to actively irradiate the tumor site.